Lactobacillus paracasei Jlus66 relieves DSS-induced ulcerative colitis in a murine model by maintaining intestinal barrier integrity, inhibiting inflammation, and improving intestinal microbiota structure

文献类型： 外文期刊

第一作者： Yu, Fazheng

作者： Yu, Fazheng;Ren, Honglin;Chang, Jiang;Guo, Jian;He, Zhaoqi;Shi, Ruoran;Hu, Xueyu;Jin, Yuanyuan;Lu, Shiying;Li, Yansong;Liu, Zengshan;Hu, Pan;Wang, Xiaoxu

作者机构：

关键词： Lactobacillus paracasei; Colitis; Intestinal biota; NF-kappa B; MAPK

期刊名称：EUROPEAN JOURNAL OF NUTRITION （ 影响因子：5.0； 五年影响因子：5.2 ）

ISSN： 1436-6207

年卷期： 2024 年

页码：

收录情况： SCI

摘要： PurposeUlcerative colitis (UC) is a serious health problem with increasing morbidity and prevalence worldwide. The pathogenesis of UC is complex, currently believed to be influenced by genetic factors, dysregulation of the host immune system, imbalance in the intestinal microbiota, and environmental factors. Currently, UC is typically managed using aminosalicylates, immunosuppressants, and biologics as adjunctive therapies, with the risk of relapse and development of drug resistance upon discontinuation. Therefore, further research into the pathogenesis of UC and exploration of potential treatment strategies are necessary to improve the quality of life for affected patients. According to previous studies, Lactobacillus paracasei Jlus66 (Jlus66) reduced inflammation and may help prevent or treat UC. MethodsWe used dextran sulfate sodium (DSS) to induce a mouse model of UC to assess the effect of Jlus66 on the progression of colitis. During the experiment, we monitored mouse body weight, food and water consumption, as well as rectal bleeding. Hematoxylin-eosin staining was performed to assess intestinal pathological damage. Protein imprinting and immunohistochemical methods were used to evaluate the protein levels of nuclear factor-kappa B (NF-kappa B), mitogen-activated protein kinase (MAPK), and tight junction (TJ) proteins in intestinal tissues. Fecal microbiota was analyzed based on partial 16S rRNA gene sequencing. ResultsJlus66 supplementation reduced the degree of colon tissue damage, such as colon shortening, fecal occult blood, colon epithelial damage, and weight loss. Supplementation with Jlus66 reduced DSS-induced upregulation of cytokine levels such as TNF-alpha, IL-1 beta, and IL-6 (p < 0.05). The NF-kappa B pathway and MAPK pathway were inhibited, and the expression of TJ proteins (ZO-1, Occludin, and Claudin-3) was upregulated. 16S rRNA sequencing of mouse cecal contents showed that Jlus66 effectively regulated the structure of the intestinal biota. ConclusionIn conclusion, these data indicate that Jlus66 can alter the intestinal biota and slow the progression of UC, providing new insights into potential therapeutic strategies for UC.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序